BRAIN Biotech AG (LON:0RFI)
London · Delayed Price · Currency is GBP · Price in EUR 2.300
0.00 (0.00%)
At close: Oct 23, 2025
BRAIN Biotech AG Market Cap
BRAIN Biotech AG has a market cap or net worth of 41.62 million as of October 28, 2025. Its market cap has decreased by -13.09% in one year.
Market Cap
41.62M
Enterprise Value
32.37M
Revenue
45.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.30
Market Cap Chart
Since February 9, 2016, BRAIN Biotech AG's market cap has decreased from 116.58M to 41.62M, a decrease of -64.30%. That is a compound annual growth rate of -10.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 41.62M | -35.28% |
| Dec 30, 2024 | 64.31M | -7.32% |
| Dec 29, 2023 | 69.39M | -38.69% |
| Dec 30, 2022 | 113.17M | -33.61% |
| Dec 30, 2021 | 170.45M | 5.04% |
| Dec 30, 2020 | 162.28M | -2.55% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.33B |
| HSBC Holdings | 172.27B |
| Shell | 164.90B |
| Unilever | 116.74B |
| Rolls-Royce Holdings | 94.34B |
| Rio Tinto Group | 90.69B |
| British American Tobacco p.l.c. | 84.96B |
| BP p.l.c. | 66.96B |